博瑞医药股价跌5%，银华基金旗下1只基金位居十大流通股东，持有291.09万股浮亏损失847.07万元

Group 1 - The core point of the news is that 博瑞医药 (Borui Pharmaceutical) experienced a 5% drop in stock price, currently trading at 55.25 yuan per share, with a total market capitalization of 23.376 billion yuan [1] - The company, established on October 26, 2001, specializes in the research and production of high-end generic drugs and original new drugs, with product sales accounting for 89.90% of its revenue [1] - The company is located in Suzhou Industrial Park, Jiangsu Province, and was listed on November 8, 2019 [1] Group 2 - Among the top shareholders of 博瑞医药, a fund under 银华基金 (Yinhua Fund) has increased its holdings by 98,300 shares in the third quarter, now holding 2.9109 million shares, representing 0.69% of the circulating shares [2] - The fund, named 创新药 (Innovation Drug), has a total scale of 12.005 billion yuan and has reported a year-to-date return of 31.41% [2] - The fund manager 马君 (Ma Jun) has a tenure of 13 years and has achieved a best fund return of 144.61% during his management period [3]